Healthcare provider profile · identity verified

Lawrence M Goldyn, M.D.

Internal Medicine · FORT BRAGG, CA · NPI 1780605097

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	709	150
Lisinopril	Lisinopril	549	132
Levothyroxine Sodium	Levothyroxine Sodium	427	85
Amlodipine Besylate	Amlodipine Besylate	316	82
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	298	38
Hydrochlorothiazide	Hydrochlorothiazide	282	79
Gabapentin	Gabapentin	270	50
Trazodone Hcl	Trazodone Hcl	242	40
Losartan Potassium	Losartan Potassium	238	58
Metoprolol Succinate	Metoprolol Succinate	194	48
Tamsulosin Hcl	Tamsulosin Hcl	186	40
Omeprazole	Omeprazole	183	50
Quetiapine Fumarate	Quetiapine Fumarate	167	suppressed
Mirtazapine	Mirtazapine	148	11
Sertraline Hcl	Sertraline Hcl	136	13
Albuterol Sulfate Hfa	Albuterol Sulfate	133	36
Rosuvastatin Calcium	Rosuvastatin Calcium	132	31
Oxycodone Hcl	Oxycodone Hcl	131	17
Baclofen	Baclofen	126	24
Eliquis	Apixaban	126	28
Furosemide	Furosemide	124	18
Potassium Chloride	Potassium Chloride	124	24
Buprenorphine Hcl	Buprenorphine Hcl	119	13
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	118	15
Ibuprofen	Ibuprofen	118	31
Venlafaxine Hcl Er	Venlafaxine Hcl	115	suppressed
Simvastatin	Simvastatin	107	18
Metoprolol Tartrate	Metoprolol Tartrate	98	21
Metformin Hcl	Metformin Hcl	95	27
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	93	suppressed
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	93	suppressed
Ropinirole Hcl	Ropinirole Hcl	91	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	86	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	85	15
Carvedilol	Carvedilol	84	15
Clopidogrel	Clopidogrel Bisulfate	79	13
Pregabalin	Pregabalin	78	18
Celecoxib	Celecoxib	76	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	11
Tivicay	Dolutegravir Sodium	69	suppressed
Metformin Hcl Er	Metformin Hcl	68	18
Hydroxyzine Hcl	Hydroxyzine Hcl	66	16
Tramadol Hcl	Tramadol Hcl	64	11
Fluoxetine Hcl	Fluoxetine Hcl	63	12
Olanzapine	Olanzapine	63	suppressed
Lorazepam	Lorazepam	61	11
Meclizine Hcl	Meclizine Hcl	61	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	60	suppressed
Morphine Sulfate Er	Morphine Sulfate	60	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	60	18
Spironolactone	Spironolactone	58	13
Acyclovir	Acyclovir	57	17
Famotidine	Famotidine	57	19
Allopurinol	Allopurinol	55	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	suppressed
Levetiracetam	Levetiracetam	53	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	53	12
Glipizide	Glipizide	51	16
Bupropion Hcl	Bupropion Hcl	49	suppressed
Finasteride	Finasteride	47	suppressed
Montelukast Sodium	Montelukast Sodium	47	13
Doxepin Hcl	Doxepin Hcl	46	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	46	suppressed
Benazepril Hcl	Benazepril Hcl	45	12
Fluticasone Propionate	Fluticasone Propionate	44	15
Pifeltro	Doravirine	44	suppressed
Lovastatin	Lovastatin	43	11
Alendronate Sodium	Alendronate Sodium	42	suppressed
Duloxetine Hcl	Duloxetine Hcl	40	suppressed
Lamotrigine	Lamotrigine	40	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	40	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	38	suppressed
Ozempic	Semaglutide	37	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Prezcobix	Darunavir/Cobicistat	36	suppressed
Etravirine	Etravirine	32	suppressed
Ketoconazole	Ketoconazole	32	16
Ventolin Hfa	Albuterol Sulfate	31	suppressed
Benztropine Mesylate	Benztropine Mesylate	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	28	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Isentress	Raltegravir Potassium	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Azelastine Hcl	Azelastine Hcl	26	suppressed
Clobetasol Propionate	Clobetasol Propionate	26	13
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Topiramate	Topiramate	26	suppressed
Atenolol	Atenolol	25	suppressed
Spiriva Respimat	Tiotropium Bromide	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Naproxen	Naproxen	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Primidone	Primidone	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Darunavir	Darunavir	19	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	19	suppressed
Estradiol	Estradiol	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	18	suppressed
Ritonavir	Ritonavir	18	suppressed
Sublocade	Buprenorphine	18	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Abacavir-Lamivudine	Abacavir Sulfate/Lamivudine	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Colchicine	Colchicine	16	suppressed
Diazepam	Diazepam	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	16	12
Valacyclovir	Valacyclovir Hcl	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Propranolol Hcl	Propranolol Hcl	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Meloxicam	Meloxicam	14	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Digoxin	Digoxin	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Lamotrigine Er	Lamotrigine	12	suppressed
Maraviroc	Maraviroc	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Nevirapine	Nevirapine	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Prednisone	Prednisone	12	suppressed
Prezista	Darunavir	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Jublia	Efinaconazole	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error